Collegium Pharmaceutical, Inc. Announces Poster Presentation for Oxycodone DETERx®, a Tamper-Resistant, Extended-Release Opioid at American Academy of Pain Management's 23rd Annual Clinical Meeting
Published: Sep 27, 2012
CUMBERLAND, R.I.--(BUSINESS WIRE)--Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today announced the presentation of a scientific poster summarizing the results for Oxycodone DETERx®, its tamper-resistant, extended-release multiparticulate formulation showing that this product may be effectively administered via sprinkling on soft foods or through enteric feeding tubes. In vivo pharmacokinetic results showing its tamper-resistant properties when chewed were also summarized. The poster, titled “Alternative Methods of Oxycodone DETERx Administration,” was presented at the American Academy of Pain Management’s 23rd Annual Clinical Meeting, held in Phoenix, Arizona from September 20th-23rd, 2012.